Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Exercise and blood sugar in postmenopausal women with type 1 diabetes

Compares aerobic and weight-lifting exercise effects on blood sugar in women with type 1 diabetes.

Plain-language title generated from the registry record
Registry title: Aerobic vs Resistance Exercise in Post-menopausal Women With Type 1 Diabetes

Key facts

Where
Edmonton and Montreal, CanadaSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 45 and 75 years old?

Source: NCT05188027, who can take part

Where in Canada

  • Alberta Diabetes InstituteEdmonton, CanadaTaking people
  • Institut de Recherches Cliniques de MontrealMontreal, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Alberta
Trial code
NCT05188027
Record updated
16 March 2026
Original description
Participants will be asked to wear a continuous glucose monitor for at least three days on three separate occasions. One testing session will be a no-exercise resting control session (90 minutes). One will be a moderate aerobic exercise session (30 minutes of exercise, 60 minutes of recovery), and the third will be a moderate weight-lifting session (~30 minutes of exercise, 60 minutes of recovery).The investigators will measure changes in blood glucose during exercise by drawing blood during and after exercise. Post-exercise glucose trends will be examined using continuous glucose monitoring.Read full original descriptionShow less

Acute Glycemic Effects of Aerobic and Resistance Exercise in Post-menopausal Women With Type 1 Diabetes

Participants will be asked to wear a continuous glucose monitor for at least three days on three separate occasions. One testing session will be a no-exercise resting control session (90 minutes). One will be a moderate aerobic exercise session (30 minutes of exercise, 60 minutes of recovery), and the third will be a moderate weight-lifting session (~30 minutes of exercise, 60 minutes of recovery).The investigators will measure changes in blood glucose during exercise by drawing blood during and after exercise. Post-exercise glucose trends will be examined using continuous glucose monitoring.

Inclusion: type 1 diabetes, diagnosed for at least one year; post-menopause (at least one year since last menstrual period), or have had a hysterectomy and bilateral salpingo oophorectomy; able to perform aerobic and resistance exercise; able to visit the lab in Edmonton, Alberta (University of Alberta).

Exclusion: history of cardiovascular disease; HbA1c > 9.9 %; use of medications (other than insulin) that affect glucose metabolism; frequent and unpredictable hypoglycemia; change in insulin management strategy within the last 2 months; blood pressure > 140 / 95; severe peripheral neuropathy; musculoskeletal injuries interfering with exercise performance; BMI > 30 kg/m2; smoking; moderate to high alcohol intake (> 2 drinks/day).

ClinicalTrials.gov NCT05188027